University of Colorado Health Researcher Discusses Findings in Sepsis (Vasoactive Agents in Burn Patients - Perspectives on Angiotensin-II).

Researchers at the University of Colorado Health have explored the use of vasoactive agents, specifically synthetic angiotensin-II (AT-II), in treating severe burn injuries and septic shock. While traditional therapies like catecholamines and vasopressin are commonly used, the potential benefits of synthetic AT-II in regulating blood pressure and improving clinical outcomes are being investigated. The study highlights the dysregulation of the renin-angiotensin-aldosterone system in burn and septic shock patients, emphasizing the need for further research in this area. [Extracted from the article]